𝔖 Bobbio Scriptorium

✦ LIBER ✦

Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids

✍ Scribed by Eduardo Shahar; Reuven Bergman; Emma Guttman-Yassky; Shimon Pollack

Book ID: 110877708
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 122 KB
Volume: 45
Category: Article
ISSN: 0011-9059
DOI: 10.1111/j.1365-4632.2006.02655.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triple therapy with ursodeoxycholic acid

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone

✍ Rabahi, N.; Chrétien, Y.; Gaouar, F.; Wendum, D.; Serfaty, L.; Chazouillères, O. 📂 Article 📅 2010 🏛 Masson Editeur 🌐 French ⚖ 201 KB

Angioedema and Angioedema Management Fro

Angioedema and Angioedema Management From Asteria I and Asteria II: Phase III Studies To Evaluate The Efficacy and Safety Of Omalizumab In Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment

✍ Zazzali, James; Rosen, Karin; Bradley, Mary S.; Raimundo, Karina 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Improvements In Health-Related Quality O

Improvements In Health-Related Quality Of Life From Asteria I & II: Phase III Studies To Evaluate The Efficacy and Safety Of Omalizumab In Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment

✍ Raimundo, Karina; Zazzali, James; Trzaskoma, Benjamin; Rosen, Karin 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A randomized trial of pegylated-interfer

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

P.279 A randomised trial of pegylated in

P.279 A randomised trial of pegylated interferon alpha-2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. Ciancio; A. Picciotto; C. Giordanino; A. Smedile; M. Tabone; A. Manca; G. Mar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Analyses of 40 kDa peginterferon alfa-2A

Analyses of 40 kDa peginterferon alfa-2A (Pegasys®) in combination with ribavirin, mycophenolate mofetil, amantadine, or amantadine plus ribavirin in patients that relapsed or did not respond to rebetron™ therapy: a report of two randomized, multicenter, efficacy and safety studies: Nezam Afdhal, Beth Israel Deaconess Medical Ctr, Boston, MA; Steven Flamm, Northwestern Memorial Hospital, Chicago, IL; Joanne C Imperial, Stanford University School of Medicine, Palo Alto, CA; Peter F Malet, University of Texas Southwestern Medical Center, Dallas, TX; Myron Tong, Hungtington Hospital Liver Center, Pasadena, CA; Steven K Herrine, Thomas Jefferson University Hospital, Philadelphia, PA; Robert Brown Jr., Columbia Presbyterian Medical Center, New York, NY; Stephen Esposito, Hepatobiliary Associates of New York, Bayside, NY; David E Bernstein, North Shore University Hospital, Manhasset, NY; Jennifer L Campagna, Roche Laboratories Inc, Nutley, NJ

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB